FMC cuts outlook on pricing, but debt cuts and new herbicide advance
Guidance cut on pricing pressure FMC lowered its 2026 revenue and profit outlook, blaming tough market conditions and falling prices for its crop chemicals. Full-year earnings per share are now expected to drop about 55% at the midpoint. Weaker profit expectations pull the stock down because investors pay for future earnings.
The guidance cut is the main new negative force on FMC's price this period.
Debt reduction progress lifts shares FMC is raising about $1 billion to pay down debt: a $400 million investment from Tessenderlo for a 20% stake, a $200 million upfront payment from Corteva, and a $252 million sale of its India business. Less debt means less risk, which helped the beaten-down stock jump 15.8%.
Debt reduction is the key positive force behind the period's sharp share rally.
New herbicide filed in Brazil FMC filed its rimisoxafen herbicide for approval in Brazil, a huge soybean and corn market, after a similar U.S. filing. It is the first herbicide with two ways of killing resistant weeds. Approval is uncertain and years away, but it supports future growth hopes.
The Brazil filing is a new pipeline event that supports FMC's long-term growth story.
Tessenderlo backs FMC as cornerstone investor Tessenderlo Group, fresh off a strong first half, confirmed its $400 million investment in FMC and its role as a cornerstone investor. A healthy, committed backer strengthens confidence in FMC's balance sheet and turnaround plan, though Tessenderlo also faces its own cost and currency pressures.
Tessenderlo's strong results reinforce confidence in its FMC investment, a positive capital signal.